Extracorporeal membrane oxygenation and congenital diaphragmatic hernia: Should any infant be excluded?

https://doi.org/10.1016/0022-3468(90)90216-VGet rights and content

Abstract

Mortality in infants with congenital diaphragmatic hernia (CDH) remains high despite improvements in neonatal and surgical care because many infants develop persistent pulmonary hypertension of the newborn (PPHN) following repair. Since 1984, extracorporeal membrane oxygenation (ECMO) has been used as rescue therapy in all infants (n = 25) with PPHN following CDH repair when conventional management failed, with an overall survival of 60%. Repair was performed in this hospital on 12 infants and in other hospitals in 13 infants transferred for consideration of ECMO after repair. Mortality was the same in the group repaired here and those transferred for ECMO. Although complications were frequent in the surviving group, they were successfully managed with nonoperative or operative therapy. Selective use of ECMO has been advocated in CDH patients based on various predictors of high mortality such as “best” PO2 postrepair <100 mm Hg, oxygenation index >40, and ventilation index >1,000 with PCO2 >40. Seven surviving infants following ECMO would have been classified as unsalvageable by at least one parameter if selection criteria based on these parameters had been used. We conclude from this series that current predictors of high mortality in CDH patients are unreliable when ECMO is used. Surgeons caring for infants with CDH should consider the use of ECMO in all infants.

References (27)

Cited by (67)

  • Anesthesia for General Surgery in the Neonate

    2016, Smith's Anesthesia for Infants and Children, Ninth Edition
  • Persistent hypercarbia after resuscitation is associated with increased mortality in congenital diaphragmatic hernia patients

    2015, Journal of Pediatric Surgery
    Citation Excerpt :

    There has been significant interest in developing and validating a clinical bedside variable that may be predictive of severe pulmonary hypoplasia and mortality in infants with CDH. A few models have been developed that utilize various clinical and laboratory markers [13–15], but there has been no consensus on a factor universally predictive of mortality [3,5,15]. Although there has been no “gold standard” for measurement of pulmonary hypoplasia, ABG values continue to best characterize pulmonary function and, ultimately, the ability of the patient to have normal gas exchange.

  • Extracorporeal Life Support for Cardiopulmonary Failure

    2012, Pediatric Surgery, 2-Volume Set: Expert Consult - Online and Print
  • Anesthesia for General Surgery in the Neonate

    2011, Smith's Anesthesia for Infants and Children: Expert Consult Premium Edition - Enhanced Online Features and Print
View all citing articles on Scopus

Presented at the 38th Annual Meeting of the Surgical Section of the American Academy of Pediatrics, Chicago, Illinois, October 21–23, 1989.

View full text